Crescita Reports First Quarter 2024 Results marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Crescita Reports Q4 and Fiscal 2023 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Crescita Therapeutics Inc. (TSE:CTX – Get Free Report) Director Jose Darocha purchased 33,500 shares of the company’s stock in a transaction dated Friday, December 22nd. The stock was purchased at an average cost of C$0.43 per share, with a total value of C$14,405.00. Crescita Therapeutics Stock Performance Crescita Therapeutics stock opened at C$0.49 on Friday. […]
Crescita Therapeutics Inc. , a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the third quarter ended September 30, 2023 . All.
Crescita Therapeutics Inc. ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the third quarter ended September 30, 2023 ("Q3-2023"). All amounts.